Phase 1 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are generally able to carry out daily activities and care for yourself with little or no limitation (doctors use a scale called ECOG to measure this, and a score of 0 or 1 is needed).
- You have been diagnosed with one of the following cancers, confirmed by a tissue or biopsy test: small cell lung cancer (SCLC), high-grade neuroendocrine or small cell cancers from outside the lung, non-small cell lung cancer (NSCLC), prostate cancer, ovarian cancer, kidney cancer (clear cell or non-clear cell), head and neck squamous cell cancer, liver cancer, stomach cancer, or triple-negative breast cancer (TNBC).
- Your cancer has gotten worse, come back, or you were unable to tolerate at least one previous standard treatment for your cancer.
- Your cancer can be measured on scans using a standard medical measuring system (confirm with trial site).
Who may not be able to join:
- You have a medical or mental health condition that the trial doctor believes could put you at risk or affect your ability to take part safely.
- You have brain or spinal cord spread of cancer that is causing symptoms, or you are currently taking steroids or anti-seizure medicines for brain metastases — though stable brain metastases with no treatment needed for at least one month may be acceptable (confirm with trial site).
- You have an active, serious infection that required antibiotic, antiviral, or antifungal treatment within the 7 days before your first dose of the trial treatment.
- You have significant heart problems (confirm with trial site for details on what qualifies).
- You have had major surgery within 28 days before starting the trial treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 385-374-1724
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs); Number of Participants with Dose-limiting Toxicity (DLT); Number of Participants with Dose Interruptions and Dose Modifications
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.